Biotech

All Articles

Daiichi spends Merck $170M to create bronchi cancer T-cell engager treaty

.Merck &amp Co. has actually promptly gotten back several of the costs of its Spear Rehabs buyout, d...

BioMarin halts preclinical genetics treatment for heart condition

.After BioMarin conducted a springtime well-maintained of its own pipe in April, the business has ch...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks deal

.Significant Pharmas stay stuck to the concept of molecular adhesive degraders. The current provider...

Life science credit agency unveils along with $600M

.A brand-new international life scientific research credit company, referred to as Symbiotic Financi...

BMS channels TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing an additional big wager from the Caforio period, ending a deal for Ag...

Nuvation halts wager prevention after taking into consideration stage 1 record

.After checking out at stage 1 record, Nuvation Bio has actually determined to halt focus on its own...

' Clinical instinct' led FDA consultants to back Zevra's unusual disease med

.Zevra Therapies' rare ailment medication appears to be on the course to permission this autumn afte...

Pfizer takes $230M reached after axing stopped working DMD gene treatment

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics treatment breakdown has actually blown a...

AC Immune observes 'landmark' potential in Alzheimer's drug data

.After greater than two decades of focus on neurodegenerative illness, Swiss biotech air conditionin...

GSK goes down ph. 2 HPV injection over absence of best-in-class possible

.GSK has actually ditched a phase 2 individual papillomavirus (HPV) injection from its own pipeline ...